Loading…
The use of traditional, complementary and integrative medicine in Chinese adolescent and young adult patients with cancer: A multicenter cross-sectional study
Adolescent and young adult (AYA) patients with cancer often experience unique physical and psychosocial complications. They may turn to traditional, complementary and integrative medicines (TCIM) to address these concerns. To examine the pattern of TCIM use among AYA patients with cancer and explore...
Saved in:
Published in: | European journal of oncology nursing : the official journal of European Oncology Nursing Society 2023-10, Vol.66, p.102377-102377, Article 102377 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13 |
container_end_page | 102377 |
container_issue | |
container_start_page | 102377 |
container_title | European journal of oncology nursing : the official journal of European Oncology Nursing Society |
container_volume | 66 |
creator | Lam, Chun Sing Ma, Chung Tin Li, Michael Can Heng Wong, Cho Lee Loong, Herbert Ho-Fung Leung, Alex Wing Kwan Li, Chi Kong Koon, Ho Kee Cheung, Yin Ting |
description | Adolescent and young adult (AYA) patients with cancer often experience unique physical and psychosocial complications. They may turn to traditional, complementary and integrative medicines (TCIM) to address these concerns. To examine the pattern of TCIM use among AYA patients with cancer and explored their preferences regarding TCIM education.
Between August 2021 and December 2022, 246 patients diagnosed with cancer between 15 and 39 years old were recruited from hospitals in Hong Kong. They completed a structured questionnaire on TCIM use, symptom burden, psychological status and preference on education content. Multivariable logistic regression was used to identify predictors of TCIM use, adjusting for age and sex.
Overall, 60.2% reported TCIM use, most commonly vitamins (24.0%) and Chinese herbal medicine (22.0%). The most common reasons for using TCIM were to improve general health (70.9%) and manage chronic symptoms (33.1%). Among patients on active treatment, TCIM users tend to report higher anxiety symptoms (aOR = 1.13, 95% CI = 1.02–1.27). TCIM users who were post-treatment were more likely to have chronic comorbidities (aOR = 3.54, 95% CI = 1.29–11.5). AYA patients indicated that they would like TCIM information to address specific needs, particularly fatigue (53.7%) and psychological problems (54.1%).
The use of TCIM is common among AYA patients with cancer, especially among patients with high symptom burdens. A tailored education programme should be provided based on patients’ preferences and needs. Healthcare professionals including oncologists and oncology nurses should communicate with AYA patients about TCIM use and address their needs by making evidence-based referrals/recommendations based on treatment status and symptom burden.
•There is growing interest in the use of TCIM among AYA patients with cancer.•Two-thirds of AYA cancer patients reported TCIM use, especially vitamins and Chinese herbs.•Among patients on active treatment, TCIM users tend to report higher anxiety symptoms.•TCIM users who were post-treatment were more likely to have chronic comorbidities.•AYA patients would like TCIM information to address fatigue and psychological problems. |
doi_str_mv | 10.1016/j.ejon.2023.102377 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2854425017</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1462388923001114</els_id><sourcerecordid>2854425017</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13</originalsourceid><addsrcrecordid>eNp9UU1v1DAUjBCIlsIf4IB85EAWf8RxgrhUKz4qVeqlPVuO_dL1KrEX2ynaP8Nv7dumcOTkp_HM6L2ZqnrP6IZR1n7eb2Afw4ZTLhDgQqkX1TmTgteccf4S56bltei6_qx6k_OeUtoL1b2uzoRq-r6h8rz6c7sDsmQgcSQlGeeLj8FMn4iN82GCGUIx6UhMcMSHAvfJFP8AZAbnrQ-AINnucEAH4-IE2aLiiX6MS7hHcJkKOaAK8Ux--7Ij1gQL6Qu5JDN--pMCErEp5lxnsOsGJJfFHd9Wr0YzZXj3_F5Ud9-_3W5_1tc3P662l9e1FbItNVdOSiabxvSqYYPqWmWEGTo7uNFYCU4yyxvuhlGytmW9cv1gDRsb1gsHjomL6uPqe0jx1wK56NnjKdNkAsQla96hOZeUKaTylfq0cIJRH5KfMSTNqD71ovf61Is-9aLXXlD04dl_GTC7f5K_RSDh60oAvPLBQ9LZYmQWc04YiXbR_8__EXhKoow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2854425017</pqid></control><display><type>article</type><title>The use of traditional, complementary and integrative medicine in Chinese adolescent and young adult patients with cancer: A multicenter cross-sectional study</title><source>ScienceDirect Freedom Collection</source><creator>Lam, Chun Sing ; Ma, Chung Tin ; Li, Michael Can Heng ; Wong, Cho Lee ; Loong, Herbert Ho-Fung ; Leung, Alex Wing Kwan ; Li, Chi Kong ; Koon, Ho Kee ; Cheung, Yin Ting</creator><creatorcontrib>Lam, Chun Sing ; Ma, Chung Tin ; Li, Michael Can Heng ; Wong, Cho Lee ; Loong, Herbert Ho-Fung ; Leung, Alex Wing Kwan ; Li, Chi Kong ; Koon, Ho Kee ; Cheung, Yin Ting</creatorcontrib><description>Adolescent and young adult (AYA) patients with cancer often experience unique physical and psychosocial complications. They may turn to traditional, complementary and integrative medicines (TCIM) to address these concerns. To examine the pattern of TCIM use among AYA patients with cancer and explored their preferences regarding TCIM education.
Between August 2021 and December 2022, 246 patients diagnosed with cancer between 15 and 39 years old were recruited from hospitals in Hong Kong. They completed a structured questionnaire on TCIM use, symptom burden, psychological status and preference on education content. Multivariable logistic regression was used to identify predictors of TCIM use, adjusting for age and sex.
Overall, 60.2% reported TCIM use, most commonly vitamins (24.0%) and Chinese herbal medicine (22.0%). The most common reasons for using TCIM were to improve general health (70.9%) and manage chronic symptoms (33.1%). Among patients on active treatment, TCIM users tend to report higher anxiety symptoms (aOR = 1.13, 95% CI = 1.02–1.27). TCIM users who were post-treatment were more likely to have chronic comorbidities (aOR = 3.54, 95% CI = 1.29–11.5). AYA patients indicated that they would like TCIM information to address specific needs, particularly fatigue (53.7%) and psychological problems (54.1%).
The use of TCIM is common among AYA patients with cancer, especially among patients with high symptom burdens. A tailored education programme should be provided based on patients’ preferences and needs. Healthcare professionals including oncologists and oncology nurses should communicate with AYA patients about TCIM use and address their needs by making evidence-based referrals/recommendations based on treatment status and symptom burden.
•There is growing interest in the use of TCIM among AYA patients with cancer.•Two-thirds of AYA cancer patients reported TCIM use, especially vitamins and Chinese herbs.•Among patients on active treatment, TCIM users tend to report higher anxiety symptoms.•TCIM users who were post-treatment were more likely to have chronic comorbidities.•AYA patients would like TCIM information to address fatigue and psychological problems.</description><identifier>ISSN: 1462-3889</identifier><identifier>EISSN: 1532-2122</identifier><identifier>DOI: 10.1016/j.ejon.2023.102377</identifier><identifier>PMID: 37499405</identifier><language>eng</language><publisher>Scotland: Elsevier Ltd</publisher><subject>Adolescent and young adult ; Cancer ; Chinese ; Complementary medicine ; Integrative medicine ; Traditional medicine</subject><ispartof>European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2023-10, Vol.66, p.102377-102377, Article 102377</ispartof><rights>2023 Elsevier Ltd</rights><rights>Copyright © 2023 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13</citedby><cites>FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37499405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lam, Chun Sing</creatorcontrib><creatorcontrib>Ma, Chung Tin</creatorcontrib><creatorcontrib>Li, Michael Can Heng</creatorcontrib><creatorcontrib>Wong, Cho Lee</creatorcontrib><creatorcontrib>Loong, Herbert Ho-Fung</creatorcontrib><creatorcontrib>Leung, Alex Wing Kwan</creatorcontrib><creatorcontrib>Li, Chi Kong</creatorcontrib><creatorcontrib>Koon, Ho Kee</creatorcontrib><creatorcontrib>Cheung, Yin Ting</creatorcontrib><title>The use of traditional, complementary and integrative medicine in Chinese adolescent and young adult patients with cancer: A multicenter cross-sectional study</title><title>European journal of oncology nursing : the official journal of European Oncology Nursing Society</title><addtitle>Eur J Oncol Nurs</addtitle><description>Adolescent and young adult (AYA) patients with cancer often experience unique physical and psychosocial complications. They may turn to traditional, complementary and integrative medicines (TCIM) to address these concerns. To examine the pattern of TCIM use among AYA patients with cancer and explored their preferences regarding TCIM education.
Between August 2021 and December 2022, 246 patients diagnosed with cancer between 15 and 39 years old were recruited from hospitals in Hong Kong. They completed a structured questionnaire on TCIM use, symptom burden, psychological status and preference on education content. Multivariable logistic regression was used to identify predictors of TCIM use, adjusting for age and sex.
Overall, 60.2% reported TCIM use, most commonly vitamins (24.0%) and Chinese herbal medicine (22.0%). The most common reasons for using TCIM were to improve general health (70.9%) and manage chronic symptoms (33.1%). Among patients on active treatment, TCIM users tend to report higher anxiety symptoms (aOR = 1.13, 95% CI = 1.02–1.27). TCIM users who were post-treatment were more likely to have chronic comorbidities (aOR = 3.54, 95% CI = 1.29–11.5). AYA patients indicated that they would like TCIM information to address specific needs, particularly fatigue (53.7%) and psychological problems (54.1%).
The use of TCIM is common among AYA patients with cancer, especially among patients with high symptom burdens. A tailored education programme should be provided based on patients’ preferences and needs. Healthcare professionals including oncologists and oncology nurses should communicate with AYA patients about TCIM use and address their needs by making evidence-based referrals/recommendations based on treatment status and symptom burden.
•There is growing interest in the use of TCIM among AYA patients with cancer.•Two-thirds of AYA cancer patients reported TCIM use, especially vitamins and Chinese herbs.•Among patients on active treatment, TCIM users tend to report higher anxiety symptoms.•TCIM users who were post-treatment were more likely to have chronic comorbidities.•AYA patients would like TCIM information to address fatigue and psychological problems.</description><subject>Adolescent and young adult</subject><subject>Cancer</subject><subject>Chinese</subject><subject>Complementary medicine</subject><subject>Integrative medicine</subject><subject>Traditional medicine</subject><issn>1462-3889</issn><issn>1532-2122</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNp9UU1v1DAUjBCIlsIf4IB85EAWf8RxgrhUKz4qVeqlPVuO_dL1KrEX2ynaP8Nv7dumcOTkp_HM6L2ZqnrP6IZR1n7eb2Afw4ZTLhDgQqkX1TmTgteccf4S56bltei6_qx6k_OeUtoL1b2uzoRq-r6h8rz6c7sDsmQgcSQlGeeLj8FMn4iN82GCGUIx6UhMcMSHAvfJFP8AZAbnrQ-AINnucEAH4-IE2aLiiX6MS7hHcJkKOaAK8Ux--7Ij1gQL6Qu5JDN--pMCErEp5lxnsOsGJJfFHd9Wr0YzZXj3_F5Ud9-_3W5_1tc3P662l9e1FbItNVdOSiabxvSqYYPqWmWEGTo7uNFYCU4yyxvuhlGytmW9cv1gDRsb1gsHjomL6uPqe0jx1wK56NnjKdNkAsQla96hOZeUKaTylfq0cIJRH5KfMSTNqD71ovf61Is-9aLXXlD04dl_GTC7f5K_RSDh60oAvPLBQ9LZYmQWc04YiXbR_8__EXhKoow</recordid><startdate>20231001</startdate><enddate>20231001</enddate><creator>Lam, Chun Sing</creator><creator>Ma, Chung Tin</creator><creator>Li, Michael Can Heng</creator><creator>Wong, Cho Lee</creator><creator>Loong, Herbert Ho-Fung</creator><creator>Leung, Alex Wing Kwan</creator><creator>Li, Chi Kong</creator><creator>Koon, Ho Kee</creator><creator>Cheung, Yin Ting</creator><general>Elsevier Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231001</creationdate><title>The use of traditional, complementary and integrative medicine in Chinese adolescent and young adult patients with cancer: A multicenter cross-sectional study</title><author>Lam, Chun Sing ; Ma, Chung Tin ; Li, Michael Can Heng ; Wong, Cho Lee ; Loong, Herbert Ho-Fung ; Leung, Alex Wing Kwan ; Li, Chi Kong ; Koon, Ho Kee ; Cheung, Yin Ting</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adolescent and young adult</topic><topic>Cancer</topic><topic>Chinese</topic><topic>Complementary medicine</topic><topic>Integrative medicine</topic><topic>Traditional medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lam, Chun Sing</creatorcontrib><creatorcontrib>Ma, Chung Tin</creatorcontrib><creatorcontrib>Li, Michael Can Heng</creatorcontrib><creatorcontrib>Wong, Cho Lee</creatorcontrib><creatorcontrib>Loong, Herbert Ho-Fung</creatorcontrib><creatorcontrib>Leung, Alex Wing Kwan</creatorcontrib><creatorcontrib>Li, Chi Kong</creatorcontrib><creatorcontrib>Koon, Ho Kee</creatorcontrib><creatorcontrib>Cheung, Yin Ting</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of oncology nursing : the official journal of European Oncology Nursing Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lam, Chun Sing</au><au>Ma, Chung Tin</au><au>Li, Michael Can Heng</au><au>Wong, Cho Lee</au><au>Loong, Herbert Ho-Fung</au><au>Leung, Alex Wing Kwan</au><au>Li, Chi Kong</au><au>Koon, Ho Kee</au><au>Cheung, Yin Ting</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The use of traditional, complementary and integrative medicine in Chinese adolescent and young adult patients with cancer: A multicenter cross-sectional study</atitle><jtitle>European journal of oncology nursing : the official journal of European Oncology Nursing Society</jtitle><addtitle>Eur J Oncol Nurs</addtitle><date>2023-10-01</date><risdate>2023</risdate><volume>66</volume><spage>102377</spage><epage>102377</epage><pages>102377-102377</pages><artnum>102377</artnum><issn>1462-3889</issn><eissn>1532-2122</eissn><abstract>Adolescent and young adult (AYA) patients with cancer often experience unique physical and psychosocial complications. They may turn to traditional, complementary and integrative medicines (TCIM) to address these concerns. To examine the pattern of TCIM use among AYA patients with cancer and explored their preferences regarding TCIM education.
Between August 2021 and December 2022, 246 patients diagnosed with cancer between 15 and 39 years old were recruited from hospitals in Hong Kong. They completed a structured questionnaire on TCIM use, symptom burden, psychological status and preference on education content. Multivariable logistic regression was used to identify predictors of TCIM use, adjusting for age and sex.
Overall, 60.2% reported TCIM use, most commonly vitamins (24.0%) and Chinese herbal medicine (22.0%). The most common reasons for using TCIM were to improve general health (70.9%) and manage chronic symptoms (33.1%). Among patients on active treatment, TCIM users tend to report higher anxiety symptoms (aOR = 1.13, 95% CI = 1.02–1.27). TCIM users who were post-treatment were more likely to have chronic comorbidities (aOR = 3.54, 95% CI = 1.29–11.5). AYA patients indicated that they would like TCIM information to address specific needs, particularly fatigue (53.7%) and psychological problems (54.1%).
The use of TCIM is common among AYA patients with cancer, especially among patients with high symptom burdens. A tailored education programme should be provided based on patients’ preferences and needs. Healthcare professionals including oncologists and oncology nurses should communicate with AYA patients about TCIM use and address their needs by making evidence-based referrals/recommendations based on treatment status and symptom burden.
•There is growing interest in the use of TCIM among AYA patients with cancer.•Two-thirds of AYA cancer patients reported TCIM use, especially vitamins and Chinese herbs.•Among patients on active treatment, TCIM users tend to report higher anxiety symptoms.•TCIM users who were post-treatment were more likely to have chronic comorbidities.•AYA patients would like TCIM information to address fatigue and psychological problems.</abstract><cop>Scotland</cop><pub>Elsevier Ltd</pub><pmid>37499405</pmid><doi>10.1016/j.ejon.2023.102377</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1462-3889 |
ispartof | European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2023-10, Vol.66, p.102377-102377, Article 102377 |
issn | 1462-3889 1532-2122 |
language | eng |
recordid | cdi_proquest_miscellaneous_2854425017 |
source | ScienceDirect Freedom Collection |
subjects | Adolescent and young adult Cancer Chinese Complementary medicine Integrative medicine Traditional medicine |
title | The use of traditional, complementary and integrative medicine in Chinese adolescent and young adult patients with cancer: A multicenter cross-sectional study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A10%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20use%20of%20traditional,%20complementary%20and%20integrative%20medicine%20in%20Chinese%20adolescent%20and%20young%20adult%20patients%20with%20cancer:%20A%20multicenter%20cross-sectional%20study&rft.jtitle=European%20journal%20of%20oncology%20nursing%20:%20the%20official%20journal%20of%20European%20Oncology%20Nursing%20Society&rft.au=Lam,%20Chun%20Sing&rft.date=2023-10-01&rft.volume=66&rft.spage=102377&rft.epage=102377&rft.pages=102377-102377&rft.artnum=102377&rft.issn=1462-3889&rft.eissn=1532-2122&rft_id=info:doi/10.1016/j.ejon.2023.102377&rft_dat=%3Cproquest_cross%3E2854425017%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-27d551544a9741b7867a3ab8cbdfac5ed51c242dbf5166197d9bca1f4193ded13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2854425017&rft_id=info:pmid/37499405&rfr_iscdi=true |